Brief Reports
Copyright ©The Author(s) 2005.
World J Gastroenterol. Oct 14, 2005; 11(38): 6038-6042
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6038
Table 1 Epidemiological and clinical data of study subjects
UC patients (95%CI)Healthy controls (95%CI)
Subjects (n)4050
Gender (female/male)20/2025/25
Mean age (yrSD)(range)41.65±15.2139.96±14.33
[36.78-46.52] (17-71)[35.89-44.03] (17-72)
Mean disease duration (mo±SD)(range)56.65±63.18
[36.44-76.86] (3-216)
Current smoking (%)9 (22.5)
Extent of UC (%)
Rectum/sigmoid9 (22.5)
Left colitis22 (55.5)
Pancolitis9 (22.5)
Activity of UC (%)
Active28 (70)
Inactive12 (30)
Extraintestinal complications (%)6 (15)
Thrombotic complications (%)2 (5)
Medical treatment
None1 (2.5)
5-ASA35 (87.5)
SASP1 (2.5)
Steroids17 (42.5)
Immunosuppressors (AZA/6-MP)11 (27.5)